Webinar 1: Preference paths and their kaizen tasks for health valuation When: 30th July 2021, 16:30 CEST (duration: 1 hour) Speakers: • Associate Prof. Benjamin Craig, Department of Economics, University of South Florida • Dr. Kim Rand, Health Services Research…
The French National Authority for Health (Haute Autorité de Santé or HAS) has recently published its first update of its official methodological guide for economic evaluation (Choix méthodologiques pour l'évaluation économique à la HAS). One of the significant changes to…
We welcome the publication of the detailed guide by Prof. Nancy Devlin, Prof. David Parkin and Dr Bas Janssen on how to analyse and report data produced by the EQ-5D. The authors have explained methods in a straightforward way, with…
EuroQol is proud to announce the launch of a new whiteboard animation 'Translating patient reported outcome measures for use around the world: the example of EQ-5D’ , providing a step-by-step overview of how to translate a PROM by showing how…
EuroQol is pleased to announce the release of the British Sign Language (BSL) version of the EQ-5D-5L instrument. This is the first sign language version that has been approved by EuroQol. The EuroQol Board and Executive Committee would like to…
In light of current situation of the Covid-19 in around the globe, where some countries (e.g., Singapore) are having second wave and in some others (e.g., Indonesia, Malaysia, India) the measures being implemented by the governments are still increasing, we…
The EuroQol Office is pleased to announce that the EQ-5D-5L User Guide is now available in Chinese (Mandarin). The User Guide provides readers with basic information on how to use the EQ-5D-5L questionnaire. Topics include administering the instrument, deriving the…
EuroQol is pleased to announce that, following an extensive programme of methodological research, an international evidence-based valuation protocol has been developed for the EQ-5D-Y instrument. Published in PharmacoEconomics, the new valuation protocol will enable the development of EQ-5D-Y value sets…
EuroQol is committed to improve decisions about health and health care throughout the world by making available EQ-5D for research on the impact of COVID-19. The EQ Office Team is handling all requests for using EQ-5D in COVID-19 research with…
As a result of the Covid-19 crisis the EuroQol Office team is working from home. We are doing our best to guarantee the level of service that you have become accustomed to. However, the current situation may impact our ability…